BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit

Updated on: January 26,2024

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit

Updated on:January 26,2024

How Leukemia Is Treated

How Leukemia Is TreatedByKaren RaymaakersUpdated on January 22, 2023Medically reviewed byDouglas A. Nelson, MDThe treatment forleukemiadepends on many factors inclu

Updated on: February 04,2024

How Leukemia Is Treated

How Leukemia Is TreatedByKaren RaymaakersUpdated on January 22, 2023Medically reviewed byDouglas A. Nelson, MDThe treatment forleukemiadepends on many factors inclu

Updated on:February 04,2024

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer

Updated on: January 03,2024

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer

Updated on:January 03,2024

Study finds a possible explanation for why immunotherapy works well for some cancer patients, but not others

by Yale UniversityCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0686Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack muta

Updated on: January 30,2024

Study finds a possible explanation for why immunotherapy works well for some cancer patients, but not others

by Yale UniversityCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0686Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack muta

Updated on:January 30,2024

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on: March 12,2024

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on:March 12,2024

Baylor College of Medicine graduate starts Speratum CR to bring his own discovery to cancer patients

by Baylor College of MedicineThis image shows pancreatic cancer cells (nuclei in blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteDr. Christian Marín-Muller&

Updated on: March 08,2024

Baylor College of Medicine graduate starts Speratum CR to bring his own discovery to cancer patients

by Baylor College of MedicineThis image shows pancreatic cancer cells (nuclei in blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteDr. Christian Marín-Muller&

Updated on:March 08,2024

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Updated on: December 30,2023

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Updated on:December 30,2023

Study finds specific microbiome tied to long-term survival of patients with pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterFlorencia McAllister, M.D. Credit: MD Anderson Cancer CenterA key difference between the few pancreatic cancer patients who survive long-term an

Updated on: July 04,2024

Study finds specific microbiome tied to long-term survival of patients with pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterFlorencia McAllister, M.D. Credit: MD Anderson Cancer CenterA key difference between the few pancreatic cancer patients who survive long-term an

Updated on:July 04,2024

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

by National University of SingaporePotential new therapeutic targets in NKTL. Credit: Dr Jianbiao ZhouA team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the N

Updated on: January 28,2024

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

by National University of SingaporePotential new therapeutic targets in NKTL. Credit: Dr Jianbiao ZhouA team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the N

Updated on:January 28,2024

Researchers describe a new resistance mechanism

by IDIBELL-Bellvitge Biomedical Research InstituteDue to the treatment with the antibody against Semaphorin 4D (anti-Sema4D), changes occur in the tumor vasculature as well as a decrease in tumor

Updated on: June 08,2024

Researchers describe a new resistance mechanism

by IDIBELL-Bellvitge Biomedical Research InstituteDue to the treatment with the antibody against Semaphorin 4D (anti-Sema4D), changes occur in the tumor vasculature as well as a decrease in tumor

Updated on:June 08,2024

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on: December 01,2024

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on:December 01,2024

Engineered white blood cells can eliminate cancer, shows study

by Melissa Pappas,University of PennsylvaniaMacrophages killing cancer cell. Credit: Susan ArnoldBy silencing the molecular pathway that prevents macrophages from attacking our own cells, Univer

Updated on: January 16,2024

Engineered white blood cells can eliminate cancer, shows study

by Melissa Pappas,University of PennsylvaniaMacrophages killing cancer cell. Credit: Susan ArnoldBy silencing the molecular pathway that prevents macrophages from attacking our own cells, Univer

Updated on:January 16,2024